Bavachin protects against diet-induced hepatic steatosis and obesity in mice

[1]  Shan Hu,et al.  Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate–Activated Protein Kinase Signaling Pathway , 2021 .

[2]  Yi Ding,et al.  Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate–Activated Protein Kinase Signaling Pathway , 2021, Hepatology.

[3]  Yan Zhang,et al.  Salidroside Activates the AMP‐Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice , 2021, Hepatology.

[4]  Jiabo Wang,et al.  Bavachin enhances NLRP3 inflammasome activation induced by ATP or nigericin and causes idiosyncratic hepatotoxicity , 2021, Frontiers of Medicine.

[5]  Cheng Wang,et al.  Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease. , 2021, European journal of pharmacology.

[6]  Liyan Wu,et al.  Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway , 2020, BMC Immunology.

[7]  A. Franchitto,et al.  Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis , 2020, Cells.

[8]  T. Cotter,et al.  NAFLD 2020: The State of the Disease. , 2020, Gastroenterology.

[9]  J. Wan,et al.  Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice. , 2020, International immunopharmacology.

[10]  M. Teimouri,et al.  Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway. , 2019, The international journal of biochemistry & cell biology.

[11]  Yan Lu,et al.  Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. , 2019, Free radical biology & medicine.

[12]  Yuan Zhou,et al.  Puerarin protects against high‐fat high‐sucrose diet‐induced non‐alcoholic fatty liver disease by modulating PARP‐1/PI3K/AKT signaling pathway and facilitating mitochondrial homeostasis , 2019, Phytotherapy research : PTR.

[13]  Wei-Chung Cheng,et al.  Bavachin attenuates LPS-induced inflammatory response and inhibits the activation of NLRP3 inflammasome in macrophages. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[14]  C. Hetz,et al.  Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. , 2018, Journal of hepatology.

[15]  I. Leclercq,et al.  Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitis , 2018, Laboratory Investigation.

[16]  Jianlin Zhou,et al.  Adipose mTORC1 Suppresses Prostaglandin Signaling and Beige Adipogenesis via the CRTC2-COX-2 Pathway , 2018, Cell reports.

[17]  Guangji Wang,et al.  Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  Yong‐Xian Cheng,et al.  Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways , 2018, Nutrients.

[19]  Y. Liu,et al.  Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis , 2018, Nature Communications.

[20]  B. Neuschwander‐Tetri,et al.  Mechanisms of NAFLD development and therapeutic strategies , 2018, Nature Medicine.

[21]  Yuguang Wang,et al.  Bavachin Induces Apoptosis through Mitochondrial Regulated ER Stress Pathway in HepG2 Cells. , 2018, Biological & pharmaceutical bulletin.

[22]  G. Shulman,et al.  Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. , 2018, Cell metabolism.

[23]  D. Mashek,et al.  Breaking fat: The regulation and mechanisms of lipophagy. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[24]  P. Saha,et al.  The constitutive lipid droplet protein PLIN2 regulates autophagy in liver , 2017, Autophagy.

[25]  C. Kahn,et al.  Thermoneutral housing exacerbates non-alcoholic fatty liver disease in mice and allows for sex-independent disease modeling , 2017, Nature Medicine.

[26]  B. Bjørndal,et al.  Increased hepatic mitochondrial FA oxidation reduces plasma and liver TG levels and is associated with regulation of UCPs and APOC-III in rats , 2017, Journal of Lipid Research.

[27]  M. Tarnopolsky,et al.  Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1 , 2016, Diabetes.

[28]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[29]  M. Noh,et al.  Bavachin from Psoralea corylifolia Improves Insulin-Dependent Glucose Uptake through Insulin Signaling and AMPK Activation in 3T3-L1 Adipocytes , 2016, International journal of molecular sciences.

[30]  F. Wang,et al.  Positive skeletal effect of two ingredients of Psoralea corylifolia L. on estrogen deficiency-induced osteoporosis and the possible mechanisms of action , 2015, Molecular and Cellular Endocrinology.

[31]  H. Kalbacher,et al.  De novo lipogenesis in health and disease. , 2014, Metabolism: Clinical and Experimental.

[32]  Alexander S. Banks,et al.  Ablation of PRDM16 and Beige Adipose Causes Metabolic Dysfunction and a Subcutaneous to Visceral Fat Switch , 2014, Cell.

[33]  A. Dhingra,et al.  Psoralea corylifolia L. (Buguchi) - folklore to modern evidence: review. , 2013, Fitoterapia.

[34]  George Q. Li,et al.  Herbal medicines for fatty liver diseases. , 2013, The Cochrane database of systematic reviews.

[35]  J. McManaman,et al.  Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease[S] , 2013, Journal of Lipid Research.

[36]  Y. Tseng,et al.  Cellular bioenergetics as a target for obesity therapy , 2010, Nature Reviews Drug Discovery.

[37]  B. S. Mohammed,et al.  Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss , 2009, Diabetes.

[38]  F. Monache,et al.  Structure-activity relationship of antibacterial chalcones. , 2008, Bioorganic & medicinal chemistry.

[39]  P. Schirmacher,et al.  Differential pattern of lipid droplet‐associated proteins and de novo perilipin expression in hepatocyte steatogenesis , 2008, Hepatology.

[40]  B. Chang,et al.  Protection against Fatty Liver but Normal Adipogenesis in Mice Lacking Adipose Differentiation-Related Protein , 2006, Molecular and Cellular Biology.

[41]  H. Nawata,et al.  ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblasts. , 2002, American journal of physiology. Endocrinology and metabolism.

[42]  M. Reed,et al.  Isolation and antihyperglycemic activity of bakuchiol from Otholobium pubescens (Fabaceae), a Peruvian medicinal plant used for the treatment of diabetes. , 1999, Biological & pharmaceutical bulletin.

[43]  V. Kadam,et al.  Psoralea corylifolia Linn.—“Kushtanashini” , 2010, Pharmacognosy reviews.

[44]  P. Schirmacher,et al.  Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis , 2008 .